Parasitic diseases have a devastating effect on public health in developing areas of the world. Research in Karl Werbovetz’s group focuses on the discovery and development of new drug candidates against the protozoan parasitic diseases leishmaniasis, trypanosomiasis, and malaria, with most of our recent efforts concentrating on visceral leishmaniasis (VL) and human African trypanosomiasis (HAT).
- 1993, PhD, University of Virginia, Chemistry
- 1988, BS, State University of New York at Binghamton, Chemistry
- Distinguished Teaching Award, 2005